Optimization of Fusogenix Proteolipid Vehicles for Extra-Hepatic Delivery of mRNA
Time: 4:15 pm
day: Day 1
Details:
- Using the Fusogenix PLV technology as a nucleic acid delivery system
- Delivery of different cargos with a focus on mRNA and decreased toxicity
- mRNA encapsulated PLV delivery targeted to extra-hepatic tissues such as lung, eye, and muscle
